A Study of Expiratory Pressure Modulation in Moderate to Severe COPD Patients - Phase 1b

NCT02585752 · clinicaltrials.gov ↗
NA
Phase
TERMINATED
Status
20
Enrollment
INDUSTRY
Sponsor class

Stopped Low recruitment

Conditions

Interventions

Sponsor

ResMed